Introduction
============

Type 2 diabetes mellitus (T2DM) is a chronic and common metabolic disease with a worldwide increase in prevalence, and is associated with severe syndrome and characterized with deficit in insulin production or sensitivity ([@B11]). Large-population investigations have revealed that diabetes mellitus is associated with Alzheimer's disease (AD) ([@B17]), mild cognitive impairment (MCI) ([@B32]), anxiety and depression ([@B2]) in Central Nervous system. AD is even considered as type 3 diabetes mellitus due to insulin resistance in the brain similar to DM in peripheral lesions. Besides, T2DM and AD often co-exist in several individuals. Recently, several clinical observations have provided significant insights into certain injuries of brain structural and functional ([@B38]). These impairment in global memory, abstracted reasoning, attention and visual-motor arrangements frequently happened in the diabetic population ([@B48],[@B49]). Moreover, insulin action in the brain was selectively impaired in T2DM, especially in the hippocampus, hypothalamus and cortex ([@B6]). The lesions of insulin action in diverse regions could be attributed to the generation of some factors such as inflammatory mediators, oxidative stress, impaired insulin receptor signaling, Aβ (β-amyloid) plaque and hyper-phosphorylated tau protein.

The medial prefrontal cortex (mPFC), a critical structure in the brain, coordinates the activities of multiple cortical regions, exerts the effects of the ongoing supervisation of information, being critical to daily work ([@B26]; [@B14]). Accordingly to a current study, memory-related brain circuits in mPFC were impaired in T2DM ([@B52]) and prefrontal atrophy who had been diagnosed ([@B29]; [@B41]). A longitudinal neuropsychological study has convincingly shown that patients with damage to PFC exhibit disorders in the higher cognitive functions ([@B10]). Clinical research indicated that the terrible executive function and memory lesion in T2DM correlated predominantly with reduced glucose metabolism in the mPFC and orbital, temporal, and cerebellum regions ([@B16]). Some studies suggested the memory dysfunction occurred in T2DM patients during acute hyperglycemia ([@B12]). The abnormal change in the insulin signaling pathway might contribute to damage the neuronal structure or function ([@B62]) in T2DM, and further disturbed the impulse conduction of the nerve, the transmitter release, information export and so on. Therefore, the mechanisms which triggered neuronal lesions in the mPFC of DM by metabolic syndrome were still a subject that scientists needed to investigate. What's more important in DM encephalopathy to our studies, BBr whether alleviated the cognitive impairment through modulating insulin signaling transduction and anti-inflammatory pathway in mPFC still require more researches to clarify.

Berberine which derives from Traditional Chinese Medicine has shown its safety and efficiency in human and animals. It is an isoquinoline alkaloid and isolated from *Coptis chinensis* Franch ([@B53]). Recently, BBr has been confirmed to have versatile functions such as anti-inflammation, anti-bacterial, hypoglycemic, cholesterol-lowing, clearance of oxygen radical, anti-cancer and a well-documented effect against dysfunction in various brain nervous systems ([@B27]). It has also been verified effective in cerebral ischemia, hypertension, hyperlipemia, mental depression, anxiety and AD ([@B1]; [@B27]). Besides, it exhibited great effects in the face of intestinal mucosal barrier dysfunction in type 2 diabetic rats ([@B19]).

Fear-stimulating events can persist even over a lifetime and is widely considered to be a highly persistent and durable form of memory ([@B4]). The mPFC modulates the expression of contextual fear conditioning ([@B34]). Increasing evidences indicated that contextual fear condition assay could be applied to appraise the lesion in PFC of AD ([@B42]; [@B60]). However, there are no investigations concerning about whether BBr could suppress DM-induced fear-conditioned cognitive defect. In our study, the contextual fear condition assay was applied to detect the effects of BBr on the fear-conditioned cognitive function of diabetic rats. Moreover, we expounded the probable mechanisms that BBr improved in ordinate inflammation and insulin pathway in mPFC of DM as well.

Materials and Methods {#s1}
=====================

Materials
---------

Monoclonal antibodies IR, PI3K, p-NF-κB^Ser536^, p-GSK3β^Ser9^, GSK3β, GLUT3, PKC𝜀, PKCη, BACE-1, APP, glial fibrillary acidic protein (GFAP) and polyclonal antibody Aβ42 were purchased from Abcam. Monoclonal antibodies p-IRS-1^Ser307^, p-AKT^Ser473^, AKT, p-JNK^Thr183/Tyr185^, JNK, p-4E-BP1^Thr37/46^, and NF-κB were obtained from CST. P-PI3K P85^Tyr467^ was purchased from absin. P-IKKβ^Y199^ was purchased from Gene Tex. P-ERK1/2 ^Thr202/Tyr204^ and ERK1/2 were purchased from Millipore. The ladder marker was obtained from Thermo scientific. STZ was purchased from biosci biotechnology Co.; Ltd. ELISA kits were purchased from BOSTER.

Animals and Treatment
---------------------

Male Wistar rats weighting about 200g (aged 4--5 weeks) were provided from Beijing vital river laboratory animal technology Co.; Ltd. Animals were housed in SPF circumstance with a 12h light/dark cycle under room temperature. Two rats were raised in a cage and replaced with clean bedding for avoiding humid disgusting environment. Except the NOR (normal group), all of the rats were raised with HSFD (high sugar and high fat diet: 67.5% standard laboratory rat chow, 10% lard, 20% sugar, 2% cholesterol and 0.5% bile salts) for 4 weeks after 2 weeks of adaptive feeding. The diabetic animal model was constructed by injecting 25mg/Kg STZ (streptozocin) through the caudal vein in the HSFD group. One week later, OGTT (oral glucose tolerance test) was applied to appraise diabetic model. Meanwhile, the STZ-treated rats which met the qualification (Post-prandial blood glucose values excess 11.2 mMol/L) were randomly separated into three groups as follows: DM group (diabetes mellitus), BBr group (187.75 mg/Kg/d) and Met group (Metformin, 184mg/Kg/d). The NOR group was given standard rat diet and water *ad libitum*, while the model group was fed with HSFD until being killed. Behavioral test and PET (Positron-Emission Tomography) imaging test were carried out prior to the sacrificed week. All experiments were guided in accordance with the Animal Care and Use Committee affiliated to the Huazhong University of Science and Technology (IACUC Number: S538).

Preparation of the Prefrontal Cortex Samples
--------------------------------------------

Brains were quickly removed and rinsed in ice-cold saline. Each set of 6 brains was embedded in paraffin after fixing by 4% paraformaldehyde for ICH (immunohistochemistry) and IF (immunofluorescence). After dissecting on a cold plate, the tissues which used for western-blot were flash frozen in liquid nitrogen and preserved -80°C until using.

Fear Condition
--------------

Fear memory was appraised as described previously with minor modification ([@B46]; [@B51]). After 3 days acclimatization, the rats were free inquiry within 120s in a 50 cm × 25 cm × 25 cm fear-chamber before the tone cue was given. On the 1st day, animals were exposed to 3 tones (85 dB, 2.7 kHz, 18 s on/off cycle) followed by 3 tone-foot shock pairings (0.8 mA for 2 s). Another 30 s was used for recovery after shock. For testing the short-memory, the same procedures were executed after 1.5 h. On the following day, the rodents were placed in the box with 3 changed tones (85 dB, 2.7 kHz, 20 s on/off cycle), no shock and 60 s intervals presenting as an extinction test of contextual fear. On the 3rd day, animals were returned to the box with a novel floor and the sides of the box were stuck on color wall paper. After the same 2 min acclimatization, 20 s tones followed with 30 s recovery were presented as same as the 1st day just without 2 s foot shock in this day. Freezing behavior was scored by the experiment equipment (AniLab Software & Instrument). To avoid the presence of olfactory cues, all of the apparatus were thoroughly cleaned with 75% ethanol and wiped with a dry towel in the intervals.

TNF-α, IL-1, and IL-18 Measurements
-----------------------------------

Over-expression of diversified pro-inflammation interleukins in the DM had been paid more attention. The supernatant samples of the homogenized tissues were added into the 96 well plates that coated with primary antibody, and disposed by means of the procedures of the manufacturer instructions individually. The O.D. value was monitored at the wavelength of 450 nm after the blue color transforming into yellow immediately. The contents of these cytokines in the sample were calculated according to the standard curve drew from the reference substance reacted in the same system.

Western Blot
------------

Sixty to eighty micrograms (μg) of total mPFC lysate samples were denatured with the gel-loading buffer at boiling water for 10 min, and followed cooling to electrophorese separation (about 15--20 μL) on 8--10% Tris-glycine polyacrylamide gels. The separated proteins were transferred into PVDF membrane (Millipore, 0.45 um) under the condition of 300 voltage, 120--180 min. BSA (Bovine Serum Albumin) was applied to block and primary antibodies were incubated 12--16 h at 4°C. The reactive protein bands were visualized using the Odyssey imaging system.

Positron-Emission Tomography (PET) Imaging
------------------------------------------

*In vivo* PET imaging was performed from the *Trans*-PET^®^ BioCaliburn^®^ 700 (Raycan Technology Co., Ltd, Suzhou, China), and the method was referred to Jin- Min Liu ([@B35]).

Prefrontal Cortex Histological Morphology Studies
-------------------------------------------------

Some slices were immunochemistry stained with primary monoclonal antibody against GFAP, Aβ42 (Abcam, United States) with the purpose to appraise the activation of astrocyte and the risk of senile plaque formation. Other sections were immunofluorescent stained with the primary antibody against NF-κB (CST, United States). Finally, observation was performed under a fluorescence microscope (Olympus).

Statistical Analysis
--------------------

Data were analyzed by Graph Pad Prism 5 software and expressed as mean ±SEM. Statistical significance was assessed by One-way ANOVA following Tukey's Post Test. *P* values \< 0.05 suggested that the level of significances was existed.

Result
======

Effect of BBr on Fear-Related Behaviors in DM Rats
--------------------------------------------------

As these characteristics of simply and quickly learning and maintain for a long time even for a lifetime, fear memory is frequently applied as a classical experimental model to study the cerebral mystery which involves in learning and memory especially in rodents ([@B3]). Compared to NOR group, DM group significantly decreased the percent freezing after accommodating for 24 h (**Figure [1B](#F1){ref-type="fig"}**: ^∗∗^*P* \< 0.01 vs. control), but BBr group increased the percent freezing (**Figure [1B](#F1){ref-type="fig"}**: ^\#^*P* \< 0.05 vs. DM) when compared to DM group. After 1.5 h, the same procedures were utilized to detect the percent freezing. As is shown in **Figure [1C](#F1){ref-type="fig"}**, compare to NOR, these stimulations did not significantly affect the acquisition of the conditioned fear response in DM group. The percent freezing in these groups were all recovered to NOR level. To further explore the influence of the conditioned fear, the changed condition which diminished the 2 s electric stimulus and prolonged the resting time for 60 s (**Figure [1A](#F1){ref-type="fig"}**) were used to analyze the fear memory response on the following day. Strikingly in **Figure [1D](#F1){ref-type="fig"}**, NOR and BBr (^\#\#^*P* \< 0.01 vs. DM) group exhibited well percent freezing across the trail. On the 3rd day, the condition was back to the criteria of the 1st day, but the 2 s electric stimulus was taken away (**Figure [1A](#F1){ref-type="fig"}**). Examination of the freezing across the trials (**Figure [1E](#F1){ref-type="fig"}**) manifested that the NOR and the drug therapy group (^\#\#^*P* \< 0.01 vs. DM; ^\#^*P* \< 0.05 vs. DM) significantly enhanced the freezing percent. The DM rats (^∗∗^*P* \< 0.01 vs. NOR) which seemly forgot the electric stimulus exhibited less freezing than NOR after triple recalls.

![Berberine ameliorates the fear-memory deficit in DM rats. **(A)** Experiment protocol. Rats were exposed to an inescapable chamber and with different cue and contextual fear, and the freezing percent was recorded during the 3 days. **(B)** The freezing percent in the 1st day after 3 days acclimatization. **(C)** The freezing percent in the 1st day after the training trail of 1.5 h later to detect the short-term memory. **(D,E)** The freezing percent in the 2nd **(D)** and 3rd **(E)** day after the training trail to further appraise the long-term memory, and assessed the protection of BBr. ^∗^*P* \< 0.05 vs. NOR; ^∗∗^*P* \< 0.01 vs. NOR; ^∗∗∗^*P* \< 0.001 vs. NOR; **^\#^***P* \< 0.05 vs. DM; **^\#\#^***P* \< 0.01 vs. DM; *n* = 8∼12.](fphar-08-00334-g001){#F1}

BBr Reduces the Insulin Resistance and Regulates Related Protein in the Insulin Signaling Pathway in mPFC of DM Rats
--------------------------------------------------------------------------------------------------------------------

Some researches indicated that the T2DM patients underlay the diabetes-related cognitive decline, and showed default-mode network in prefrontal cortex ([@B13]). Insulin signaling pathway was recognized as an association with cognitive function and aging, and disordered signaling pathway might be correlated with memory impaired ([@B62]). These dysfunction symptoms were prominent in AD and DM. Obviously, as showed in **Figure [2A](#F2){ref-type="fig"}**, there were no significant changes on IR (insulin receptor) protein levels in all of our groups. But the expression of p-IRS-1^Ser307^ was significantly increased in DM group (**Figure [2B](#F2){ref-type="fig"}**), BBr and Met remarkably reduced the increment (^∗∗∗^*P* \< 0.001 vs. NOR; ^\#^*P* \< 0.05 vs. DM; ^\#\#\#^*P* \< 0.001 vs. DM). Next, we detected the phosphorylation of related proteins of insulin signaling pathway and found that most of them were up-regulated in DM group (**Figure [3](#F3){ref-type="fig"}**). As showed in **Figure [3A](#F3){ref-type="fig"}**, DM group remarkably increased the expression of p-PI3K when compared to NOR group, but BBr and Met groups obviously reduced its level (^∗∗^*P* \< 0.01 vs. NOR; ^\#^*P* \< 0.05 vs. DM). The same influence occurred in the Akt kinase (**Figure [3B](#F3){ref-type="fig"}**) that involved in cellular survival pathway. For the BBr and Met groups, they similarly largely attenuated p-Akt^Ser473^ expressions (^∗^*P* \< 0.05 vs. NOR; ^\#^*P* \< 0.05 vs. DM). By measuring the alterations of p-GSK3β^Ser9^, we found that upregulated p-GSK3β^Ser9^ was also inhibited by the isoquinoline alkaloid BBr (^∗^*P* \< 0.05 vs. NOR; ^\#^*P* \< 0.05 vs. DM) when compared with DM group (**Figure [3C](#F3){ref-type="fig"}**). The biguanide antidiabetic drug Met exhibited a few effects on this protein involved in regulating glycogen synthase. These weird scenes stimulate us to take the activation of mTOR into consideration. Obviously in **Figure [3D](#F3){ref-type="fig"}**, the substrate protein p-4E-BP1 of mTOR was degraded and BBr inhibited this phenomenon.

![Effect of BBr on insulin resistance in the mPFC of DM rats. **(A)** BBr did not change the expression of insulin receptor, *n* = 4 for western-blot. **(B)** BBr reduced the enhanced expression of p-INS-1^Ser307^, *n* = 3 for western-blot. ^∗∗∗^*P* \< 0.001 vs. NOR; **^\#^***P* \< 0.05 vs. DM. **^\#\#\#^***P* \< 0.001 vs. DM.](fphar-08-00334-g002){#F2}

![Regulation of PI3K/Akt/mTOR insulin pathway by BBr in the mPFC of DM rats. **(A--D)** BBr reduced the enhanced expressions of p-PI3K ^Tyr467^ **(A)**, p-Akt^Ser473^ **(B)**, p-GSK3β^Ser9^ **(C)**, and p-4E-BP1^Thr37/46^ **(D)** in the mPFC of DM, *n* = 3∼5 for western-blot. ^∗^*P* \< 0.05 vs. NOR; ^∗∗^*P* \< 0.01 vs. NOR; **^\#^***P* \< 0.05 vs. DM; **^\#\#^***P* \< 0.01 vs. DM.](fphar-08-00334-g003){#F3}

Effect of BBr on Inflammation Signaling Pathway in mPFC of DM Rats
------------------------------------------------------------------

Because a large number of different researches indicated that inflammation could be increased by stress responses which come from peripheral immune and central immune cells released cytokines. Inflammation and its accompanied stress responses are common to neuroplasticity alternation in DM ([@B50]; [@B55]). To determine whether BBr have anti-inflammation effects in the prefrontal cortex, we detected the phosphorylation levels of NF-κB and IKK. As showed in **Figures [4A,B](#F4){ref-type="fig"}**, the phosphorylation levels of the IKK and NF-κB were greatly augmented in DM group (^∗^*P* \< 0.05 vs. NOR; ^∗∗^*P* \< 0.01 vs. NOR). In contrast, BBr (^\#^*P* \< 0.05 vs. DM) strongly reduced these protein′s expression as same as the Met group (^\#^*P* \< 0.05 vs. DM). For further verifying the inflammation was occurred in astrocyte and was inhibited by BBr, we adopted the immunohistochemistry assay to observe the expression level of GFAP, a marker of astrocyte, in the mPFC of DM rats. Obviously, an urgent increment was showed in DM group when compared to NOR, while these positive expressions were largely decreased by BBr and Met (**Figure [4C](#F4){ref-type="fig"}**). Next we investigated the inflammatory factors in mPFC and found that BBr did not significantly affect IL-1β and TNF-α except IL-18 (**Figures [4D](#F4){ref-type="fig"}--[F](#F4){ref-type="fig"}**). IL-18 level (**Figure [4D](#F4){ref-type="fig"}**) was obviously increased, but a little increment about IL-1β (**Figure [4E](#F4){ref-type="fig"}**) and TNF-α (**Figure [4F](#F4){ref-type="fig"}**) also showed in DM when compared with NOR. BBr strikingly suppressed the increment as Met. Based on these observations, we further detected MAPK signaling pathway and found that p-JNK was remarkably enhanced and a few increment about p-ERK in DM (**Figures [4G,H](#F4){ref-type="fig"}**). These results indicated that BBr reduced the generation of inflammation, the activation of astrocyte and MAPK signaling pathway in mPFC of DM.

![Effect of BBr on inflammation mediators in the mPFC of DM rats. **(A,B)** BBr reduced the increased expression of p-IKK^Y\ 199^ and p- NF-κB^Ser536^ in the mPFC of DM rats, *n* = 3 for western-blot. **(C)** The immunochemistry showed that the increased expression of GFAP in the mPFC of DM rats was largely inhibited by BBr, *n* = 4 for immunochemistry. **(D--F)** BBr decreased the inflammation cytokine IL-18 **(D)**, but had no effect on IL-1β **(E)**, and TNF-α **(F)** in the mPFC of DM rats, *n* = 8∼10 for ELISA. ^∗^*P* \< 0.05 vs. NOR; ^∗∗^*P* \< 0.01 vs. NOR; **^\#^***P* \< 0.05 vs. DM. **(G,H)** BBr reduced the increased expression of p-ERK and p-JNK in the mPFC of DM rats, *n* = 3 for western-blot.](fphar-08-00334-g004){#F4}

BBr Promotes the Uptake of Glucose in the Brain of DM Rats and Increases the Metabolism of Glucose in Neuron
------------------------------------------------------------------------------------------------------------

The standard uptake value was described to evaluate the glucose uptake *in vivo* PET imaging. The SUV mean was decreased about three times in DM group when compared to NOR, conversely, BBr largely enhanced the value and Met had no effect (**Figure [5A](#F5){ref-type="fig"}**). For the expression level of GLUT3, it was significantly suppressed in DM group (^∗^*P* \< 0.05 vs. NOR) when compared to NOR, but remarkably increased by BBr (^\#\#\#^*P* \< 0.001 vs. DM), and slightly increased by Met (**Figure [5B](#F5){ref-type="fig"}**). Then we detected the expression of the vital protein kinase C (PKC) which regulated glucose transporter from the cytoplasm to membrane. As showed in **Figure [5C](#F5){ref-type="fig"}**, the levels of two isoforms PKC𝜀 and PKCη (^∗^*P* \< 0.05 vs. NOR;^\#^*P* \< 0.05 vs. DM; ^\#\#^*P* \< 0.01 vs. DM) which came from novel subfamilies co-increased in DM group, whereas their expressions in BBr and Met group were decreased effectively. Meanwhile, we adopted the immunofluorescence assay to observe the translocation of NF-κB from cytoplasm to nucleus. As indicated in **Figure [5D](#F5){ref-type="fig"}**, the neuron marker Neu-N and transcription factor NF-κB were co-stained in the mPFC. The expression of the NF-κB in the nucleus of the DM neuron was obviously increased. Both BBr and Met remarkably blocked the nuclear translocation of NF-κB (**Figure [5D](#F5){ref-type="fig"}**).

![Uptake of glucose in rat brain and expression of GLUT3 in neuron of the mPFC. **(A)** The standard uptake value was described to evaluate the glucose uptake *in vivo* PET imaging. The standard uptake value mean was obviously augmented by BBr, *n* = 3 for PET imaging. **(B)** The down-regulation of the GLUT3 in the mPFC of DM rats was remarkably increased by BBr from Western blot showing, *n* = 3 for western-blot. **(C)** The expression of n-PKC in the mPFC of DM rats was remarkably inhibited by BBr, *n* = 3 for western-blot. **(D)** The translocation of NF-κB in the mPFC of DM rats was remarkably inhibited by BBr, *n* = 3 for immunofluorescence. ^∗^*P* \< 0.05 vs. NOR; ^∗∗∗^*P* \< 0.001 vs. NOR; **^\#\#^***P* \< 0.01 vs. DM.**^\#\#\#^***P* \< 0.001 vs. DM.](fphar-08-00334-g005){#F5}

Effect of BBr on Aβ42 Production in mPFC of DM Rats
---------------------------------------------------

Accumulating reports indicated that the dysregulation of the insulin signaling pathway and the presentation of the inflammation favored the Aβ42 production and the formation of senile plaques which were the principal pathological hallmarks of AD ([@B22]). We next investigated the protein changes involved the Aβ42 production in mPFC of DM rats. As showed in **Figure [6A](#F6){ref-type="fig"}**, the APP was obviously increased in DM group. BBr strongly reduced the expression level of APP which was induced by diabetes, and Met had the same effects. In addition, we determined the BACE-1 (beta-site amyloid precursor protein cleaving enzyme 1) level (**Figure [6B](#F6){ref-type="fig"}**), it was surprising that Met had no effect on the enzyme BACE-1 as same as the DM group. This phenomenon was in harmony with other groups ([@B9]). Contrast to Met group, BBr could almost reverse the status. We found that BBr could suppress the expression of the BACE-1 up to almost two times. Moreover, the production of Aβ42 in mPFC of DM rats was distinctly reduced by BBr (**Figure [6C](#F6){ref-type="fig"}**). But almost a little reduction was appeared in Met group when compared to DM group.

![Effect of BBr on amyloid-β formation. **(A,B)** The amyloid precursor protein (APP) and BACE-1 presented in the mPFC of DM rats were remarkably reduced by BBr. However, Met just restrained the APP expression and had no effect on BACE-1, *n* = 3 for western-blot. **(C)** The generation of Aβ42 was effectively inhibited by BBr and Met might play a little effect, *n* = 3 for immunochemistry. **^∗^***P* \< 0.05 vs. NOR; **^\#^***P* \< 0.05 vs. DM; **^\#\#^***P* \< 0.01 vs. DM.](fphar-08-00334-g006){#F6}

Discussion
==========

The cognitive changes induced by diabetes have been acknowledged. Most clinical researches proved the connectivity around the mPFC was impaired in patients with T2DM ([@B13]). Recent results also suggest that DM could partly affect the dendritic morphology in the occipital cortex, prefrontal cortex and hippocampus ([@B38]). Aβ accumulation in the brain is the feature of aging and cognitive ability is decreased during the development of pathophysiology, especially in AD and MCI induced by DM ([@B37]). A number of studies had proved that inflammation promoted the Aβ peptide to aggregate rapidly ([@B47]). Moreover, inflammation also disturbed the insulin signaling pathway; conversely, aberrant insulin signaling pathway exacerbated the inflammation production ([@B43]), and led to more Aβ peptide aggregation and impaired cognitive function ([@B47]). This study indicated for the first time that monomeric BBr administration modulated aberrant insulin signaling pathway, reduced inflammatory mediators and improved the lesion of cognitive in DM rats.

Met is widely used as a first-line treatment for patients with T2DM. Previous studies demonstrated that Met could rapidly cross the blood-brain barrier ([@B28]) and had several beneficial effects in the brain, such as anti-inflammatory ([@B57]) and neuroprotective effects ([@B21]). Meanwhile, Met could alleviate the impairment of cognitive function in db/db mice ([@B31]; [@B8]). Many clinic trails were also shown that long-term treatment with Met could reduce the risk of cognitive decline ([@B20]; [@B44]). So Met is one of the best candidates for the positive control in the DM-induced cognitive impaired model.

Here, we used the contextual fear condition assay to test BBr on the improvement of the cognitive function. On the 1st day, we found the freezing percent in DM group was decreased (**Figure [1B](#F1){ref-type="fig"}**) when compared to NOR. BBr group seemingly quickly remembered the influence of stimulation and significantly increased the freezing percent (**Figure [1B](#F1){ref-type="fig"}**). After 1.5-h intervals, the percent freezing in DM groups was almost recovered to NOR level (**Figure [1C](#F1){ref-type="fig"}**). The same results also emerged in the drug groups in our study. This might indicate the retrieval of information in short-term memory, no matter DM group and the treatment groups, almost all recovered up to normal level. Besides, the results probably also suggested that BBr group dealt with problems more quickly when compared to DM group (**Figures [1B,C](#F1){ref-type="fig"}**). On the next day, the freezing percent in DM group was decreased once again than in the 1st day when detection was executed after 1.5 h, but no significant changes were found in BBr (**Figure [1D](#F1){ref-type="fig"}**). These observations indicated that BBr accelerated the reinforcement of the information. Meanwhile, BBr still significantly augmented the freezing percent when compared to DM after 24 h. The same results occurred in the 3rd day, and Met also ameliorated the fear memory defect. It may imply that long-term memory, rather than short-term memory is impaired in DM and BBr could effectively inhibit the cognitive impairment. Moreover, BBr seemed to reduce cognitive impairment which caused by DM earlier than Met (**Figures [1D,E](#F1){ref-type="fig"}**).

Desensitized insulin receptor signaling was involved in both AD and DM. In most of the previous literature, it had been demonstrated that venenous Aβ oligomer caused partial loss of insulin receptor in dendritic spine mainly in aged primary hippocampus neurons, with increased distribution of insulin receptor in the cell soma but no alternations in absolute IR subunit levels, rendering insulin receptor non-responsive in the AD brain ([@B63]). In the present study, our results also showed that no distinctive changes of the IR protein levels in mPFC of the four groups (**Figure [2A](#F2){ref-type="fig"}**). Of course, this result needs more experiments to classify whether IR internalization was generated. Phospho-Ser307 in IRS-1 blocks the interaction between the IRS-1 PTB domain and insulin receptor, which might weaken the coupling between the two proteins ([@B39]) and lead to insulin resistance. Our results distinctly revealed the increased p-IRS-1^ser307^ in DM group was significantly reduced by BBr. The condition of insulin resistance in the mPFC of DM rats was also inhibited by Met (**Figure [2B](#F2){ref-type="fig"}**). Additionally, the ROS generation which mediated by HG-induced also activated the aberrantly PI3K/Akt signaling pathway ([@B30]). Chronically excessive activation of Akt also caused the development of Tau pathological and Aβ42 generation under insulin resistant situation in db/db and HSFD mouse brains ([@B24]). In our study, activated PI3K/ Akt signaling pathway of DM-induced was remarkably inhibited in BBr and Met groups (**Figures [3A,B](#F3){ref-type="fig"}**). Similarly, the excessive activation or overexpression of GSK3β could trigger a series of pathological alterations, most of which are hallmarks of T2DM and AD ([@B15]). Additionally, overproduction of APP also obviously activated the GSK3β in the hippocampus of APP-V717I amyloid transgenic mice ([@B54]). In our research, the increased p-GSK3β^Ser9^ protein was significantly rectified by BBr in the mPFC of DM as well (**Figure [3C](#F3){ref-type="fig"}**). In additionally, the activation of mTOR signaling pathway was involved in inflammation transduction ([@B59]) and facilitation of neurodegeneration in AD ([@B58]). Obviously, the decreased mTOR substrate p-4E-BP1 (Thr37/46) in our experiment (**Figure [3D](#F3){ref-type="fig"}**) indicated that the PI3K/Akt/mTOR signaling was activated. This is coherent to other group ([@B23]). In summary, these results ascertained that activated PI3K/Akt/mTOR in DM group might accelerate the generation of Aβ (**Figures [3A](#F3){ref-type="fig"}--[D](#F3){ref-type="fig"}**).

There is a close relationship between the impairment of cognitive function and the activation of inflammatory pathways ([@B33]). The transcription factor NF-κB was a key protein involved in cellular responses to stimulations such as oxidation stress, ultraviolet irradiation, bacterial, cytokines and so on. The release of the NF-κB is an initiation of the degradation of IκB proteins via activation of a kinase IKK. Our previous researches indicated that BBr attenuates the production of inflammatory mediators through suppression of TLR4 (toll-like receptor 4)/NF-κB signaling in intestine tissue of diabetic rats. The present work was performed to study the anti-inflammation effect of BBr in mPFC of DM rats. The activation of n-PKC also attributed to the upregulation of NF-κB. We speculated that BBr not only reduced the phosphorylation levels of IKKβ and NF-κB (**Figures [4A,B](#F4){ref-type="fig"}**), but also suppressed the upregulation of n-PKC (**Figure [5C](#F5){ref-type="fig"}**). Moreover, as showed in **Figure [4C](#F4){ref-type="fig"}**, the expression of FGAP in DM group was inhibited by BBr as well as Met. Meanwhile, the increased protein levels of pro-inflammation IL-18 (**Figure [4D](#F4){ref-type="fig"}**) in DM group were significantly decreased by BBr in the supernatant fluids of the tissue homogenate, but few effects on IL-1β and TNF-a (**Figures [4E,F](#F4){ref-type="fig"}**) were found. In additionally, the activation of MAPK signaling pathway was involved in inflammation transduction ([@B61]) and facilitation of neurodegeneration in AD ([@B25]). Our results also ascertained that activated JNK (**Figure [4H](#F4){ref-type="fig"}**) was showed in DM group and BBr decreased the increment. The sustained neuroprotective effects of BBr observed in the present study is consistent with the research about protecting against neuronal damage via suppression of inflammation in traumatic brain injury ([@B7]). Taken together, our findings suggested that BBr developed its neuroprotective function against cognitive deficits in DM rats via inhibiting the production of inflammation in astrocyte.

Then we focus on the uptake and metabolism of glucose in the mPFC of DM brain. *In vivo* PET imaging is a common method to detect the uptake of glucose in brain. The impairment of glucose uptake in the brain of T2DM aggravated the pathological alteration. This phenomenon also emerges in our research. In **Figure [5A](#F5){ref-type="fig"}**, the shiny red color which represented the uptake of glucose in NOR was completely disappeared in the DM. The therapeutic drug BBr obviously recovered the uptake of glucose. Met had a slightly increment. Of note, the high density of GLUT3 in neurons was pivotal in the energy supplement and neuronal activities. Moreover, the impaired glucose uptake/metabolism was also inversely correlated to the densities of NFTs (Neurofibrillary tangles) ([@B36]). In our study, the decreased GLUT3 was presented in the mPFC of DM rats (**Figure [5B](#F5){ref-type="fig"}**). Traditional Chinese medicine BBr could largely enhance GLUT3 expression and reverse the lesion. Emerging evidence indicated that protein kinase C epsilon (PKC𝜀) participated in insulin-regulated trafficking of the glucose transporter GLUT4 in adipocytes ([@B56]). Then, we determined the expression level of PKC and found that these conclusions were more or less discrepant with our discoveries. As show in our results (**Figure [5C](#F5){ref-type="fig"}**), both of two novel Ca^2+^-insensitive isoforms of PKC were activated under insulin resistance. The distinct scene might be a negative feedback regulation in the mPFC, and BBr effectively blunt the increase extent of n-PKC (novel-PKC) in DM rats as well as Met. This was coherent to some researches ([@B5]; [@B18]) that more than one PKC isoform in DM were activated by hyperglycemia, since many PKC isoforms were DAG-dependent style. Nevertheless some reports indicated that PKC𝜀 activation was required for recognition memory in the rats' hippocampus ([@B64]). Meanwhile, the translocation of NF-κB was also increased in neuron of mPFC of DM rats. This might indicate that the neuron in DM group had some capacities to resist the generation of damages. But, the exact molecular mechanism needs further investigation. Overall, related proteins were activated in mPFC of DM in the insulin signaling pathway except GLUT3 in neuron, this scene might involve in some other cells activation but not neuron, just as the astrocyte. These results indicate that BBr not only facilitates glucose metabolism in mPFC, but also promotes the uptake of glucose, even in the DM rats under cognitive impairment.

It is well known that Aβ42 is the primary pathogenic factor in AD. Growing evidences indicated that DM was one of the upper most risk factors for developing AD and accelerated Aβ42 pathological changes ([@B40]). APP is best known as the precursor molecule whose proteolysis generates Aβ. It was reasonable to observe the incremental levels of APP and BACE-1 in mPFC of DM (**Figures [6A,B](#F6){ref-type="fig"}**) because their increases also appeared in monkey with DM ([@B45]). The administration of BBr can reduce the incremental levels of APP and BACE-1 in mPFC of DM (**Figures [6A,B](#F6){ref-type="fig"}**) and clean the oligomeric toxic protein Aβ42 (**Figure [6C](#F6){ref-type="fig"}**). However, it remains unknown how BBr promote the reduction of APP levels. In this regard, it still needs great efforts to examine the underlying mechanisms about the effect on transcriptional inhibition or translation degeneration. As the mentioned above, insulin sensitization agent Met reduced the APP level, but the enzyme BACE-1 level was largely augmented. This co-action might accelerate the Aβ42 production as in DM and this discovery had been reported before ([@B9]). There are maybe some reasons, such as rapid degradation or some other kinase activities were enhanced, ascribe to the weaker function in Met group.

Conclusion
==========

Our present findings (**Figure [7](#F7){ref-type="fig"}**) suggest that BBr not only modulated the aberrant inflammation responses, but also regulated some in ordinate proteins of insulin signaling pathway in the mPFC of DM rats. Moreover, it promoted the uptake of glucose in the brain of DM rats and increased the metabolism of glucose in neuron. These results probably more clearly elucidate that BBr exhibits the importance of multi-targets in the mPFC of DM. Moreover, these apparently protective actions of BBr prevent diabetes-associated cognitive decline in DM rats.

![Possible mechanism of BBr for ameliorating the cognitive impairment in DM rats.](fphar-08-00334-g007){#F7}
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